Bicycle Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bicycle Therapeutics generated cash of -$60,628,000, which is more than the previous year. Cash used in financing activities reached the amount of $250,027,000 last year. Net change in cash is therefore $187,816,000.
Cash Flow
| 2017 | -1.41M | -1.11M | 57.87M |
|---|---|---|---|
| 2018 | -26.07M | -1.18M | 25.43M |
| 2019 | -28.61M | -1.55M | 58.44M |
| 2020 | -17.78M | -1.2M | 62.84M |
| 2021 | -14.79M | -2.03M | 320.72M |
| 2022 | -86.11M | -18.98M | 6.69M |
| 2023 | -60.62M | -2.92M | 250.02M |
BCYC Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 339.15M | 438.68M | 135.99M | 92.11M | 63.38M | 67.66M | 9.40M |
Operating activities | |||||||
Net income | -180.66M | -112.71M | -66.81M | -51.01M | -30.60M | -21.84M | -16.25M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 6.54M | 3.68M | 1.40M | 1.27M | 960K | 712K | 332K |
Stock-based compensation expense | 32.47M | 26.77M | 12.08M | 6.51M | 3.08M | 0 | 515K |
| Deferred income tax benefit | 32.47M | 26.77M | 12.08M | 6.51M | 3.08M | 0 | 515K |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 2.48M | -1.64M | 4.54M | -2.14M | 4.90M | -400K | -1.42M |
Inventories | 0 | 0 | -4.79M | 4.16M | -2.55M | -2.11M | 0 |
Accounts payable | 8.00M | 2.56M | 1.19M | -663K | 220K | -169K | 67K |
Cash generated by operating activities | -60.62M | -86.11M | -14.79M | -17.78M | -28.61M | -26.07M | -1.41M |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -2.92M | -18.98M | -2.03M | -1.2M | -1.55M | -1.18M | -1.11M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -2.92M | -18.98M | -2.03M | -1.2M | -1.55M | -1.18M | -1.11M |
Financing activities | |||||||
Common Stock Issued | 249.34M | 5.70M | 298.54M | 48.14M | 56.95M | 1K | 58.49M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -14.99M | -14.53M | 0 | 0 | 0 |
Cash used in financing activities | 250.02M | 6.69M | 320.72M | 62.84M | 58.44M | 25.43M | 57.87M |
Net Change In Cash | 187.81M | -99.52M | 302.69M | 43.87M | 28.73M | -4.28M | 58.26M |
Cash at end of period | 526.97M | 339.15M | 438.68M | 135.99M | 92.11M | 63.38M | 67.66M |
| Data source | Data source | Data source | Data source | Data source |